title: Oxidative stress and NFkappaB activation in the lungs of rats: a synergistic interaction between soot and iron particles.
abstract: Particulate matter (PM) has been associated with a variety of adverse health effects primarily involving the cardiopulmonary system. However, the precise biological mechanisms to explain how exposure to PM exacerbates or directly causes adverse effects are unknown. Particles of varying composition may play a critical role in these effects. To study such a phenomenon, a simple, laminar diffusion flame was used to generate aerosols of soot and iron particles in the ultrafine size range. Exposures of healthy adult rats were for 6 h/day for 3 days. Conditions used included exposure to soot only, iron only, or a combination of soot and iron. We found animals exposed to soot particles at 250 microg/m3 had no adverse respiratory effects. Exposure to iron alone at a concentration of 57 microg/m3 also had no respiratory effects. However, the addition of 45 microg/m3 of iron to soot with a combined total mass concentration of 250 microg/m3 demonstrated significant pulmonary ferritin induction, oxidative stress, elevation of IL-1beta, and cytochrome P450s, as well as activation of NFkappaB. These findings suggest that a synergistic interaction between soot and iron particles account for biological responses not found with exposure to iron alone or to soot alone.
authors.affiliation: Center for Health and the Environment, Department of Anatomy, Physiology, and Cell Biology, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.
authors.forename: Ya-Mei
authors.initials: YM
authors.lastname: Zhou
authors.forename: Cai-Yun
authors.initials: CY
authors.lastname: Zhong
authors.forename: Ian M
authors.initials: IM
authors.lastname: Kennedy
authors.forename: Valerie J
authors.initials: VJ
authors.lastname: Leppert
authors.forename: Kent E
authors.initials: KE
authors.lastname: Pinkerton
mesh_terms: D000280:Administration, Inhalation; D000336:Aerosols; D000818:Animals; D001973:Bromodeoxyuridine / Q000378:metabolism; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry / Q000166:cytology; D002244:Carbon / Q000032:analysis / Q000633:toxicity*; D002455:Cell Division / Q000187:drug effects; D016207:Cytokines / Q000378:metabolism; D004357:Drug Synergism; D005978:Glutathione / Q000032:analysis; D007501:Iron / Q000032:analysis / Q000633:toxicity*; D008168:Lung / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D008297:Male; D016328:NF-kappa B / Q000096:biosynthesis*; D018384:Oxidative Stress / Q000502:physiology*; D010316:Particle Size; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D000336:Aerosols; D016207:Cytokines; D016328:NF-kappa B; D002244:Carbon; D007501:Iron; D001973:Bromodeoxyuridine; D005978:Glutathione